Data set management

The data sets currently supported by the Pilot Climate Data System (PCDS) are listed, many of which are Level II and Level III NImbus-7 data sets. Those data sets planned for future access through the PCDS were also listed, and their current installation status was stated. The tasks involved in supporting data sets within the PCDS were identified and described. After a data set is approved for implementation into the system and communication with the data producers is established, the information for the detailed catalog entry is gathered. This information then is reviewed with the scientists involved before producing a catalog summary. Once this is done, the catalog information can be provided to users, even before the data set is installed. The next several tasks involve software development and can prove to be the most time-consuming aspect in the data set support. These tasks can be simplified if the data producers provide complete and accurate documentation of their product. Software for reading and interpreting the data sets is developed and the data sets, or portions therefore, that will be made available for use within the PCDS are inventoried. Users can access this information via the INVENTORY Subsystem of the PCDS

NIMBUS-5 sounder data processing system. Part 2: Results

The Nimbus-5 spacecraft carries infrared and microwave radiometers for sensing the temperature distribution of the atmosphere. Methods developed for obtaining temperature profiles from the combined set of infrared and microwave radiation measurements are described. Algorithms used to determine (a) vertical temperature and water vapor profiles, (b) cloud height, fractional coverage, and liquid water content, (c) surface temperature, and (d) total outgoing longwave radiation flux are described. Various meteorological results obtained from the application of the Nimbus-5 sounding data processing system during 1973 and 1974 are presented

Daily weather direct readout microprocessor study

The work completed included a study of the requirements and hardware and software implementation techniques for NIMBUS ESMR and TWERLE direct readout applications using microprocessors. Many microprocessors were studied for this application. Because of the available Interdata development capabilities, it was concluded that future implementations be on an Interdata microprocessor which was found adequate for the task

Data catalog series for space science and applications flight missions. Volume 4B: Descriptions of data sets from meteorological and terrestrial applications spacecraft and investigations

The main purpose of the data catalog series is to provide descriptive references to data generated by space science flight missions. The data sets described include all of the actual holdings of the Space Science Data Center (NSSDC), all data sets for which direct contact information is available, and some data collections held and serviced by foreign investigators, NASA and other U.S. government agencies. This volume contains narrative descriptions of data sets from meteorological and terrestrial applications spacecraft and investigations. The following spacecraft series are included: Mariner, Pioneer, Pioneer Venus, Venera, Viking, Voyager, and Helios. Separate indexes to the planetary and interplanetary missions are also provided

Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies

Background The goal of hepatorenal syndrome type 1 (HRS-1) treatment is to improve renal function. Terlipressin, a synthetic vasopressin analogue, is a systemic vasoconstrictor used for the treatment of HRS-1, where it is available. Aim To compare the efficacy of terlipressin plus albumin vs. placebo plus albumin in patients with HRS-1. Methods Pooled patient-level data from two large phase 3, randomised, placebo-controlled studies were analysed for HRS reversal [serum creatinine (SCr) value ≤133 μmol/L], 90-day survival, need for renal replacement therapy and predictors of HRS reversal. Patients received intravenous terlipressin 1–2 mg every 6 hours plus albumin or placebo plus albumin up to 14 days. Results The pooled analysis comprised 308 patients (terlipressin: n = 153; placebo: n = 155). HRS reversal was significantly more frequent with terlipressin vs. placebo (27% vs. 14%; P = 0.004). Terlipressin was associated with a more significant improvement in renal function from baseline until end of treatment, with a mean between-group difference in SCr concentration of −53.0 μmol/L (P \u3c 0.0001). Lower SCr, lower mean arterial pressure and lower total bilirubin and absence of known precipitating factors for HRS were independent predictors of HRS reversal and longer survival in terlipressin-treated patients. Conclusions Terlipressin plus albumin resulted in a significantly higher rate of HRS reversal vs. albumin alone in patients with HRS-1. Terlipressin treatment is associated with improved renal function